...
首页> 外文期刊>Chirality: The pharmacological, biological, and chemical consequences of molecular asymmetry >Development and validation of a chiral LC-MS method for the enantiomeric resolution of (+) and (-)-medetomidine in equine plasma by using polysaccharide-based chiral stationary phases
【24h】

Development and validation of a chiral LC-MS method for the enantiomeric resolution of (+) and (-)-medetomidine in equine plasma by using polysaccharide-based chiral stationary phases

机译:用多糖的手性固定阶段通过多糖的手性静脉阶段对(+)和( - - ) - ( - ) - ( - ) - ( - ) - ( - ) - ( - ) - 中苯胺中的映体分辨率的手性LC-MS方法的开发和验证

获取原文
获取原文并翻译 | 示例
           

摘要

The detection and separation of medetomidine enantiomers from the complex biological matrices poses a great analytical challenge, especially in the field of forensic toxicology and pharmacology. Couple of researchers reported resolution of medetomidine using protein-based chiral columns, but the reported method is quiet challenging and tedious to be employed for routine analysis. This research paper reported a method that enables the enantio-separation of medetomidine by using polysaccharide cellulose chiral column. The use of chiralcel OJ-3R column was found to have the highest potential for successful chiral resolution. Ammonium hydrogen carbonate was the ideal buffer salt for chiral liquid chromatography (LC) with electrospray ionization (ESI)+ mass spectrometry (MS) detection for the successful separation and detection of racemic compound. The method was linear over the range of 0 to 20 ng/mL in equine plasma and the inter-day precisions of levomedetomidine, dexmedetomidine were 1.36% and 1.89%, respectively. The accuracy of levomedetomidine was in the range of 99.25% to 101.57% and that for dexmedetomidine was 99.17% to 100.99%. The limits of quantification for both isomers were 0.2 ng/mL. Recovery and matrix effect on the analytes were also evaluated. Under the optimized conditions, the validated method can be adapted for the identification and resolution of the medetomidine enantiomers in different matrices used for drug testing and analysis.
机译:来自复杂生物基质的Medetomidine对映异构体的检测和分离构成了巨大的分析挑战,特别是在法医毒理学和药理学领域。几个研究人员报告了使用基于蛋白质的手性柱的Mebetomidine的分辨率,但报告的方法是安静的挑战性和繁琐的常规分析。本研究论文报道了一种方法,通过使用多糖纤维素手性柱来实现脑映瘤的酶分离。发现使用Chiralcel OJ-3R柱具有成功的手性分辨率的最高潜力。碳酸氢铵是具有电喷雾电离(ESI)+质谱(MS)检测的手性液相色谱(LC)的理想缓冲盐,用于成功分离和检测外消旋化合物。该方法在马血浆中线性在0至20ng / ml的范围内,Levomedetomidine的白芽间精度分别为1.36%和1.89%。 Levomedetomidine的准确性为99.25%至101.57%,对于Dexmedetomidine为99.17%至100.99%。两种异构体的量化极限为0.2ng / ml。还评估了对分析物的回收率和基质效应。在优化的条件下,验证的方法可以适用于用于药物测试和分析的不同基质中的Medetomidine对映体的鉴定和分辨。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号